Understanding the risk for infection in patients with neutropenia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Genomic Insights into Azole Resistance Mechanisms in Candida tropicalis Among Hematological Malignancy Patients with Candidemia.Current microbiology · 2025
   Article
2. Implications for neutrophils in cardiac arrhythmias.American journal of physiology. Heart and circulatory physiology · 2024
   Review
3. Clozapine for the treatment of aggressiveness and agitation in advanced dementia.Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2023
   Article
4. [Psychopharmacotherapy during the COVID-19 pandemic].Der Nervenarzt · 2020
   Review
5. Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis.ESMO open · 2018
   Review
6. The High Prevalence of Functional Complement Defects Induced by Chemotherapy.Frontiers in immunology · 2016
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as